<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000599993"><TermName>memantine hydrochloride</TermName><TermPronunciation>(MEH-mun-teen HY-droh-KLOR-ide)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat dementia caused by Alzheimer disease. It is also being studied in the treatment of side effects from whole-brain radiation therapy for cancer and other conditions. Memantine hydrochloride blocks the uptake of calcium by certain brain cells and decreases their activity. It is a type of N-methyl-D-asparatate (NMDA) receptor antagonist. Also called Namenda.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000721218" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;memantine hydrochloride&quot;" language="en" id="_3"/><MediaLink ref="CDR0000721217" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de memantina&quot;" language="es" id="_4"/><SpanishTermName>clorhidrato de memantina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la demencia que causa la enfermedad de Alzheimer. Asimismo, está en estudio para el tratamiento de los efectos secundarios de la radioterapia dirigida a todo el cerebro utilizada para tratar el cáncer y otras afecciones. El clorhidrato de memantina bloquea la reabsorción del calcio de ciertas neuronas y reduce su actividad. Es un tipo de antagonista del receptor de N-metil-D-aspartato (NMDA). También se llama Namenda.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-07-14</DateFirstPublished></GlossaryTerm>
